| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |